Drug distributors like Cardinal Health, Cencora and McKesson will play a key role in the drug supply chain, improving patient ...

Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

In February, Johnson & Johnson and the 'big three' US pharma wholesalers – McKesson, Cardinal Health, and AmerisourceBergen – said they were close to a $26 billion settlement. Teva's ...

None of the competitors can replicate Ebos’ combined scale across community pharmacy and institutional drug distribution and as a result we believe its relative cost advantage should persist ...